Publication Name	World Journal of Cardiology
Manuscript ID	3359
Country	Greece

Received	2013-04-25 11:57
Peer-Review Started	2013-04-25 20:52
To Make the First Decision	2013-05-14 18:55
Return for Revision	2013-05-18 16:58
Revised	2013-05-19 23:48
Second Decision	2013-06-18 09:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-06-19 00:08
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-07-11 18:58
Publish the Manuscript Online	2013-08-02 14:08

ISSN	1949-8462 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Field of Vision
Article Title	High density lipoprotein and cardiovascular diseases
Manuscript Source	Invited Manuscript
All Author List	Theodosios D Filippatos and Moses S Elisaf
Funding Agency and Grant Number
Corresponding Author	Moses S Elisaf, MD, FRSH, FASA, FISA, Professor, Department of Internal Medicine, School of Medicine, University of Ioannina, Staurou Niarchou Avenue, 45110 Ioannina, Greece. egepi@cc.uoi.gr
Key Words	High density lipoprotein; Functionality; Structure; Cardiovascular risk; Niacin; Cholesteryl ester transfer protein inhibitors
Core Tip	Epidemiological studies have shown that low plasma levels of high density lipoprotein cholesterol (HDL-C) represent a cardiovascular disease (CVD) risk factor. However, recent studies challenge the concept that an increase of plasma HDL-C will uniformly translate into a reduction in CVD risk. Certain patients with atherosclerosis may have “dysfunctional” HDL despite normal HDL-C levels. Furthermore, HDL-C levels are influenced by dietary patterns, drugs or concomitant diseases. The association of the structure of HDL particle with its functionality and metabolism has not been fully clarified. More research is needed to assess the association of HDL functionality with CVD risk.
Publish Date	2013-08-02 14:08
Citation	Filippatos TD, Elisaf MS. High density lipoprotein and cardiovascular diseases. World J Cardiol 2013; 5(7): 210-214
URL	http://www.wjgnet.com/1949-8462/full/v5/i7/210.htm
DOI	http://dx.doi.org/10.4330/wjc.v5.i7.210

Full Article (PDF)	WJC-5-210.pdf
Manuscript File	3359-Review.doc
Answering Reviewers	3359-Answering reviewers.doc
Copyright License Agreement	3359-Copyright assignment.doc
Peer-review Report	3359-Peer review(s).pdf
Scientific Editor Work List	3359-Scientific editor work list.doc